Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.

Phoenix Spree to pay disposal fee to drum up cash for shareholders

Heavily disounted Berlin residential real estate fund caps its manager's annual charge below last year's level but agrees new 1% disposal fee to increase property sales to drive cash for its suspended dividend.

James Carthew: Don’t wind down Aquila European Renewables

Our columnist explains why it would be a shame if London’s only Europe-focused renewables fund failed its continuation vote next week.

AVI Global buys stake in ‘misvalued’ News Corp

Bargain hunter Joe Bauernfreund puts over 3% of his trust in Rupert Murdoch's publishing group believing media mogul will take steps to correct a 53% share price discount.

Richard Buxton retires from Jupiter after four-decade career

Buxton said that he will pursue his passion for the arts in retirement, but that investing is still ‘in my blood’.

Bill Ackman backs Jamie Dimon for US president

The Pershing Square fund manager says that the 67-year-old JP Morgan Chase boss would ‘know how to bring opposing parties together’ and can defeat both Biden and Trump.

Augmentum: The AI revolution and light in fintech’s tunnel

Augmentum Fintech chief executive Tim Levene assesses the threat and opportunity in artificial intelligence and predicts fintech will exit the bear market at the end of this year.

Commercial property in strongest position for three years

2022 was an annus horribilis for property investors, but lower valuations have left the sector on a solid footing with rental growth the 'big story', says Custodian Property Income’s Richard Shepherd-Cross.

Orbimed’s Polischuk: Biotech has lift-off following harshest bear market

The biotech sector has rebounded after its harshest bear market, in part thanks to clarity on US drug pricing reform, says Worldwide Healthcare investment trust manager Trevor Polischuk.

Biotech has lift-off following harshest bear market

The biotech sector has rebounded after its harshest bear market, in part thanks to clarity on US drug pricing reform, says Worldwide Healthcare manager Trevor Polischuk.

Hardenberg predicts EM revival after lost decade

Emerging markets have traded sideways in the past decade and lost ground over five years, but Mobius’s Carlos Hardenberg expects them to re-rate from a deep discount.

Mobius’ Hardenberg predicts EM revival after lost decade

Emerging markets have traded sideways in the past decade and lost ground over five years, but Mobius’ Carlos Hardenberg expects them to re-rate from a deep discount.

Nick Train: Beating unloved UK market ‘not good enough’

Finsbury Growth & Income’s concentrated quality stock picks might have doubled this year’s UK stock market return but that’s not enough for its fund manager who eyes the more impressive gains of the Nasdaq US technology index.